JEEVAN WAGASKAR (Guest) 18th Jan 2017 at 05:33 pm	for long term perspective its good but in short te rm not satisfied.
Ravi Joshi (Guest) 5th Dec 2016 at 04:10 pm	Rightly said !!! Ill-intentions of Management are clearly visible from the fact that, they have increased Eq. Capital from about Rs. 25 Crores to present Rs. 100 Crores just before the launch of the IPO !!!
Sharma, L.V. 5th Dec 2016 at 04:09 pm	Think it will list at a premium looking at the FDA approvals that are in pl ace and prospects of the industry.
Kamal Garg (Guest) 5th Dec 2016 at 10:08 am	Agree with the analysis and high valuation sought for the IPO.
sharad gupta 3rd Dec 2016 at 09:18 pm	As expected indepth & honest analysis. Thanks & regards